Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 91.35% |
| 2 | Consumer Staples | 2.31% |
| 3 | Technology | 1.26% |
| 4 | Financials | 1.12% |
| 5 | Healthcare | 1.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4151
Marriott Vacations Worldwide
VAC
$3.79B
| $1.4M | ﹤0.01% |
19,100
+11,900
| +165% | +$883K |
|
4152
iShares Russell Top 200 ETF
IWL
$2.26B
| $1.4M | ﹤0.01% |
28,297
-27,361
| -49% | -$1.34M |
|
4153
Invesco High Yield Equity Dividend Achievers ETF
PEY
$1.17B
| $1.4M | ﹤0.01% |
87,866
+77,135
| +719% | +$1.21M |
|
4154
PUT
ProShares Ultra Gold
UGL
$852M
| $1.4M | ﹤0.01% |
126,800
+60,800
| +92% | +$691K |
|
|
CRR
4155
DELISTED
Carbo Ceramics Inc.
CRR
| $1.39M | ﹤0.01% |
127,387
+33,570
| +36% | +$431K |
|
|
SNV
4156
CALL
DELISTED
Synovus
SNV
| $1.39M | ﹤0.01% |
42,800
+22,900
| +115% | +$719K |
|
4157
Pacific Biosciences
PACB
$435M
| $1.39M | ﹤0.01% |
155,226
-146,568
| -49% | -$1.23M |
|
4158
CALL
Banco Santander
SAN
$213B
| $1.39M | ﹤0.01% |
329,217
+29,843
| +10% | +$122K |
|
4159
Mercer International
MERC
$25.9M
| $1.39M | ﹤0.01% |
164,130
-28,248
| -15% | -$235K |
|
4160
Invesco S&P Spin-Off ETF
CSD
$224M
| $1.39M | ﹤0.01% |
32,404
-41,709
| -56% | -$1.76M |
|
4161
CALL
Viavi Solutions
VIAV
$9.02B
| $1.39M | ﹤0.01% |
188,000
+56,600
| +43% | +$415K |
|
4162
iShares Currency Hedged MSCI EAFE ETF
HEFA
$7.51B
| $1.39M | ﹤0.01% |
55,943
+17,231
| +45% | +$420K |
|
4163
PUT
iShares MSCI Spain ETF
EWP
$2.24B
| $1.39M | ﹤0.01% |
51,700
-117,500
| -69% | -$3.07M |
|
|
DF
4164
PUT
DELISTED
Dean Foods Company
DF
| $1.39M | ﹤0.01% |
84,600
+3,800
| +5% | +$66.4K |
|
4165
iShares Russell Top 200 Growth ETF
IWY
$16B
| $1.39M | ﹤0.01% |
+24,812
| New | +$1.38M |
|
4166
CALL
iShares US Financials ETF
IYF
$4.31B
| $1.39M | ﹤0.01% |
30,800
+17,600
| +133% | +$789K |
|
4167
PUT
Lamar Advertising Co
LAMR
$15.3B
| $1.39M | ﹤0.01% |
21,200
+2,400
| +13% | +$155K |
|
4168
United States Natural Gas Fund
UNG
$520M
| $1.39M | ﹤0.01% |
10,358
-46,028
| -82% | -$6.08M |
|
|
QEP
4169
CALL
DELISTED
QEP RESOURCES, INC.
QEP
| $1.39M | ﹤0.01% |
70,900
-40,000
| -36% | -$737K |
|
4170
CALL
Itron
ITRI
$4.27B
| $1.38M | ﹤0.01% |
24,800
+12,500
| +102% | +$599K |
|
4171
PUT
Travelzoo
TZOO
$68.2M
| $1.38M | ﹤0.01% |
+107,800
| New | +$1.2M |
|
4172
CALL
ProShares UltraShort Yen
YCS
$30.3M
| $1.38M | ﹤0.01% |
91,200
+16,800
| +23% | +$261K |
|
|
CHS
4173
PUT
DELISTED
Chicos FAS, Inc.
CHS
| $1.38M | ﹤0.01% |
116,200
-62,200
| -35% | -$735K |
|
4174
PUT
ProShares Ultra Dow30
DDM
$585M
| $1.38M | ﹤0.01% |
+116,400
| New | +$1.39M |
|
4175
Global X FinTech ETF
FINX
$175M
| $1.38M | ﹤0.01% |
+89,754
| New | +$1.36M |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass's Q3 2016 filing shows 1,347 new, 3,278 increased, 3,435 reduced and 1,488 closed positions. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M. The largest sale was Apple, an estimated $762M.
By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, down from 93% a quarter earlier, followed by Consumer Staples and Technology.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.